The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2☆☆☆★
To access this article, please choose from the options below
☆ Supported in part by a grant from Datascope Corp, Montiale, NJ, and Genentech Inc, South San Francisco, Calif.
☆☆ Reprint requests: Hal V. Barron, MD, 1 DNA Way, South San Francisco, CA 94080. E-mail: barron.hal@gene.com
★ The first author, Hal V. Barron, is an employee of Genentech Inc, South San Francisco, Calif.
PII: S0002-8703(01)56961-6
doi:10.1067/mhj.2001.115295
© 2001 Mosby, Inc. All rights reserved.
Refers to article:
- Aortic counterpulsation in acute myocardial infarction: Physiologically important but does the patient benefit?
